This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Bed Bath & Beyond (BBBY) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Bed Bath & Beyond (BBBY) reports solid Q4 results, despite sluggishness during the holiday season and higher clearance activities. Management holds back FY20 view due to CVOID-19 impacts.
5.25M More Jobless Claims, Plus Starts & Permits, Philly Fed Down
by Mark Vickery
Initial and Continuing Jobless Claims, Housing Starts and Building Permits, and the Philly Fed join the latest batch of Q1 earnings reports this morning.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Rite Aid (RAD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of -184.62% and 1.21%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?
Rite Aid Adds new Testing Site, Supports Coronavirus Relief Efforts
by Zacks Equity Research
Rite Aid (RAD) adds another testing location at a Rite Aid store in Pennsylvania to help curb the effects of coronavirus pandemic.
Coronavirus Ruining Portfolio? Give These 4 Retailers a Shot
by Sumit Singh
As people are working from home and maintaining social distancing, there are players in the industry focusing on bolstering omni-channel operations and ramping up delivery services.
Rite Aid (RAD) Prioritizes Actions Amid Coronavirus Woes
by Zacks Equity Research
Rite Aid (RAD) has been working at the forefront by providing essential goods and medicines as well as assisting with coronavirus testing and virus-related information.
Xcel Brand's (XELB) Q4 Earnings Decline Y/Y, Revenues Rise
by Zacks Equity Research
Robust wholesale and e-commerce businesses contribute to Xcel Brands' (XELB) Q4 results. However, no guidance has been issued, given the unprecedented COVID-19 impacts.
Will Rite Aid's (RAD) Strategies Continue to Aid Q4 Earnings?
by Zacks Equity Research
Rite Aid's (RAD) fourth-quarter fiscal 2020 results are likely to reflect gains from increased Medicare Part D membership and improved pharmacy network as well as enhanced wellness offerings.
Rite Aid (RAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rite Aid Continues Hiring to Support Coronavirus Relief Efforts
by Zacks Equity Research
In the wake of the COVID-19 crisis, Rite Aid (RAD) is gearing up to serve customers better by hiring staff. Also, its newly-launched Hero plan bodes well.
Factors Setting the Tone for Rite Aid's (RAD) Q4 Earnings
by Zacks Equity Research
Rite Aid (RAD) is expected to have witnessed soft front-end sales in fourth-quarter fiscal 2020, due to restrictions on sale of tobacco in New York, and over-the-counter cough-cold and flu products.
Rite Aid (RAD) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
by Zacks Equity Research
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: SFM, COST, CASY and RAD
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SFM, COST, CASY and RAD
5 Retail Picks for a Dose of Confidence Amid Coronavirus-Crisis
by Sumit Singh
Experts believe that once the coronavirus spread is contained, the retail sector, which touches every sphere of our life, is likely to witness a sharp rebound.
Are There Any Stocks to Buy in Coronavirus-Hit Retail Sector?
by Sumit Singh
Experts believe that once the coronavirus spread is contained and vaccine discovered, the retail sector, which touches every sphere of our life, is likely to witness a sharp rebound.
Has Rite Aid (RAD) Outpaced Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Is (RAD) Outperforming Other Retail-Wholesale Stocks This Year?
Do Options Traders Know Something About Rite Aid (RAD) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.
Walgreens Boots Alliance (WBA) in Focus: Stock Moves 6.5% Higher
by Zacks Equity Research
Walgreens Boots Alliance (WBA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Rite Aid Joins Fight Against COVID-19 by Expanding Services
by Zacks Equity Research
In the wake of the COVID-19 crisis, Rite Aid (RAD) is gearing up to serve customers better by providing home delivery and pick-up services.
New Strong Buy Stocks for March 18th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Should You Invest in the SPDR S&P Retail ETF (XRT)?
by Sweta Killa
Sector ETF report for XRT
Things You Must Know Before Gap (GPS) Reports Q4 Earnings
by Zacks Equity Research
Gap's (GPS) Q4 results are expected to reflect the impacts of continued softness in comps and margins. Cancelled Old Navy spin-off and the robust online business might have aided performance.
Here's How DICK'S Sporting (DKS) Looks Ahead of Q4 Earnings
by Zacks Equity Research
DICK'S Sporting's (DKS) fourth-quarter fiscal 2019 results are expected to reflect gains from the review of its hunting business as well as omni-channel and merchandising strategies.
5 Reasons to Buy These Small-Cap Stocks Now
by Sanghamitra Saha
After a painful stretch, small-cap U.S. stocks should rebound on a few tailwinds.